MARKET

SRTS

SRTS

Sensus Healthcare Inc
NASDAQ
2.325
-0.895
-27.80%
After Hours: 2.325 0 0.00% 19:30 11/13 EST
OPEN
3.160
PREV CLOSE
3.220
HIGH
3.280
LOW
2.311
VOLUME
194.53K
TURNOVER
--
52 WEEK HIGH
5.49
52 WEEK LOW
2.311
MARKET CAP
38.27M
P/E (TTM)
-2.3829
1D
5D
1M
3M
1Y
5Y
1D
Sensus Healthcare: Buy Rating Reaffirmed on Growing SRT Adoption and International Potential; $6 Price Target Unchanged
TipRanks · 9h ago
Sensus Healthcare (SRTS) Q3 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Sensus Healthcare reports Q3 EPS (9c), consensus (4c)
TipRanks · 2d ago
Press Release: Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
Dow Jones · 2d ago
*Sensus Healthcare 3Q Loss/Shr 9c >SRTS
Dow Jones · 2d ago
Press Release: Sensus Healthcare Reports Third -3-
Dow Jones · 2d ago
Press Release: Sensus Healthcare Reports Third -2-
Dow Jones · 2d ago
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
Barchart · 2d ago
More
About SRTS
Sensus Healthcare, Inc. is a medical device company. The Company is engaged in the development and delivery of non-invasive treatments for non-melanoma skin cancer (NMSC) and post-surgical keloid scar prevention. The Company uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is incorporated into a portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT technology is used to effectively and safely treat oncological and non-oncological skin conditions. The SRT-100 is a photon x-ray low-energy SRT system that provides patients with an alternative to surgery for treating NMSC, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with an SRT-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and comprehensive dosimetry parameters.

Webull offers Sensus Healthcare Inc stock information, including NASDAQ: SRTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRTS stock methods without spending real money on the virtual paper trading platform.